Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Striosomal ghrelin receptor activity controls reward-cost integration.

Research square·2026

Same author

Prediction error correlates in the striosome-dopamine circuit emerge from information gain.

Nature communications·2026

Same author

Adverse outcomes during delivery hospitalizations among patients with diabetes and an intellectual or developmental disability diagnosis.

American journal of obstetrics & gynecology MFM·2026

Same author

Risks and benefits of prenatal exposure to antidepressants: Neurobiological mechanisms and clinical evidence.

General physiology and biophysics·2026

Same author

Variations in Eclampsia Risk Across Asian Origin Groups in the United States.

Maternal and child health journal·2026

Same author

Elucidating an anterior cingulate circuit for self-initiated actions and rescue of Parkinsonian akinesia.

bioRxiv : the preprint server for biology·2026

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Decoding of dopaminergic mesolimbic activity and depressive behavior.

Alexander Friedman¹, Ilana Deri, Yaakov Friedman

¹Leslie Susan Gonda (Goldschmied) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 52900, Israel.

Journal of Molecular Neuroscience : MN

|September 18, 2007

Summary

Researchers found that altered dopamine cell activity in the ventral tegmental area (VTA) is linked to depression. Antidepressant treatment normalized this activity and reduced depressive symptoms in rats, suggesting new therapeutic targets.

More Related Videos

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Related Experiment Videos

Last Updated: Jul 11, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

Neuroscience
Pharmacology
Computational Biology

Background:

Dopaminergic systems (mesolimbic and mesocortical) are crucial for motivation and pleasure, yet their role in depression pathophysiology is understudied.
Previous research indicated reduced limbic dopamine (DA) neurotransmission in Flinders Sensitive Line (FSL) rats, an animal model of depression.

Purpose of the Study:

To investigate the relationship between the bursting activity patterns of dopamine cells in the ventral tegmental area (VTA) and dopamine release efficiency in the nucleus accumbens.
To explore the effects of antidepressant treatment on VTA dopamine cell activity, dopamine release, and depressive-like behaviors in FSL rats.

Main Methods:

Utilized a phase-space algorithm to analyze the bursting-like activity of VTA dopamine cells.
Measured dopamine release efficiency in the accumbens.
Administered the antidepressant desipramine to FSL rats and assessed its impact on VTA cell firing complexity, accumbens dopamine release, and behavior.

Main Results:

A strong correlation was observed between VTA dopamine cell bursting activity patterns and dopamine release efficiency in the accumbens.
VTA dopamine cell bursting in FSL rats exhibited low-dimensional complexity.
Desipramine treatment normalized VTA cell firing complexity and accumbens dopamine release, while also alleviating depressive-like behaviors.

Conclusions:

Limbic dopaminergic system dynamics, particularly VTA dopamine cell activity, are implicated in depression.
Non-linear analysis of dopaminergic activity shows potential for monitoring and understanding depression.
Targeting dopaminergic system functionality may offer novel strategies for antidepressant drug development.